HPC Biosciences Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on HPC Biosciences's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Food Industry Growth	17.6%
Revenue growth rate	n/a
Return on equity	n/a
Net Margin	n/a
Last Earnings Update	31 Mar 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How HPC Biosciences makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:535217 Revenue, expenses and earnings (INR Millions)
Date	Revenue	Earnings	G+A Expenses
31 Mar 23	2	0	1
31 Dec 22	2	-3	2
30 Sep 22	2	-6	2
30 Jun 22	3	-6	2
31 Mar 22	5	-5	2
31 Dec 21	13	3	1
30 Sep 21	22	11	1
30 Jun 21	22	11	1
31 Mar 21	23	12	1
31 Dec 20	17	8	1
30 Sep 20	13	4	1
30 Jun 20	13	4	1
31 Mar 20	12	3	1
31 Dec 19	14	6	1
30 Sep 19	17	8	1
30 Jun 19	17	7	1
31 Mar 19	16	6	1
31 Dec 18	17	2	1
30 Sep 18	17	-2	1
30 Jun 18	19	0	2
31 Mar 18	21	2	2
31 Dec 17	23	4	2
30 Sep 17	21	6	4
30 Jun 17	23	6	3
31 Mar 17	24	5	2
31 Dec 16	19	3	3
30 Sep 16	16	2	2
30 Jun 16	18	3	2
31 Mar 16	20	5	2
31 Dec 15	26	6	3
30 Sep 15	32	6	5
30 Jun 15	32	7	4
31 Mar 15	33	7	3
31 Dec 14	37	10	3
30 Sep 14	41	14	3
30 Jun 14	38	13	3
31 Mar 14	35	12	3

Quality Earnings: Insufficient data to determine if 535217 has high quality earnings.

Growing Profit Margin: Insufficient data to determine if 535217's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 535217's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare 535217's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if 535217's earnings growth over the past year exceeded the Food industry average.

Return on Equity

High ROE: 535217 has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/10/26 07:57
End of Day Share Price	2024/07/29 00:00
Earnings	2023/03/31
Annual Earnings	2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HPC Biosciences Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.